Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M103527200 on September 12, 2001

J. Biol. Chem., Vol. 276, Issue 46, 42893-42900, November 16, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/46/42893    most recent
M103527200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pombo, I.
Right arrow Articles by Blank, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pombo, I.
Right arrow Articles by Blank, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

IgE Receptor Type I-dependent Regulation of a Rab3D-associated Kinase

A POSSIBLE LINK IN THE CALCIUM-DEPENDENT ASSEMBLY OF SNARE COMPLEXES*

Isabel PomboDagger §, Sophie Martin-VerdeauxDagger , Bruno IannascoliDagger , Joëlle Le MaoDagger , Ludovic DerianoDagger , Juan Rivera, and Ulrich BlankDagger ||

From the Dagger  Unité d'Immuno-Allergie, Institut Pasteur, 75724 Paris Cedex 15, France and the  Molecular Inflammation Section, NIAMS, National Institutes of Health, Bethesda, Maryland 20892

Received for publication, April 20, 2001, and in revised form, September 11, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Following activation through high affinity IgE receptors (Fcepsilon RI), mast cells release, within a few minutes, their granule content of inflammatory and allergic mediators. Fcepsilon RI-induced degranulation is a SNARE (soluble N-ethylmaleimide attachment protein receptors)-dependent fusion process. It is regulated by Rab3D, a subfamily member of Rab GTPases. Evidence exists showing that Rab3 action is calcium-regulated although the molecular mechanisms remain unclear. To obtain an understanding of Rab3D function we have searched for Rab3D-associated effectors that respond to allergic triggering through Fcepsilon RI. Using the RBL-2H3 mast cell line we detected a Ser/Thr kinase activity, termed here Rak3D (from Rab3D-associated kinase), because it was specifically co-immunoprecipitated with anti-Rab3D antibody. Rak3D activity, as measured by its auto- or transphosphorylation, was maximal in resting cells and decreased upon stimulation. The down-regulation of the observed activity was blocked with EGTA, but not with other degranulation inhibitors, suggesting that its activity functions downstream of calcium influx. We found that Rak3D phosphorylates the NH2-terminal regulatory domain of the t-SNARE syntaxin 4, but not syntaxin 2 or 3. The phosphorylation of syntaxin 4 decreased its binding to its partner SNAP23. Thus, we propose a novel phosphorylation-dependent mechanism by which Rab3D controls SNARE assembly in a calcium-dependent manner.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mast cells are specialized immune cells able to secrete a variety of mediators stored in cytoplasmic granules and involved in inflammatory and allergic responses (1). Upon activation, they can discharge almost their entire granular content by compound exocytosis (2, 3). A potent physiological stimulus for degranulation is the antigen-dependent aggregation of IgE bound to high affinity IgE receptors (Fcepsilon RI).1 This activates both membrane-attached and cytoplasmic tyrosine kinases that pave the way for the intracellular calcium increase that is necessary for secretion (4-6).

The accumulated evidence demonstrates that during regulated exocytosis calcium can act directly on the molecular machinery involved in membrane fusion. An essential part of this machinery are SNARE proteins (7). During neurotransmitter release at the synapse, SNAREs assemble into an extremely stable multimeric core complex composed of one v-SNARE2 (synaptobrevin or vesicular-associated membrane protein = VAMP) and two t-SNAREs2 (syntaxin 1 and SNAP25) (8-10). Complex formation is thought to provide the necessary energy to bring together the two opposing membranes and drive bilayer mixing. SNARE complex formation is regulated by additional positive and negative effectors (8, 10). These include small GTPases of the Rab3 family (8, 11, 12). In mast cells, degranulation also depends on SNARE-mediated fusion but instead utilizes SNAP23, a SNAP25 homolog and syntaxin 4 (13, 14) as well as the calcium sensor synaptotagmin (15). Rab3D also plays an important role in regulating the fusion process in mast cells (16, 17) but the mechanism by which it exerts its role is unknown.

Rab proteins regulate membrane traffic in eucaryotic cells by organizing the assembly of effector molecules (18, 19). Rab-mediated functions include membrane tethering of organelles (20), calcium-dependent fusion (21, 22), and movement of vesicles along the cytoskeleton (23-25). While many Rab proteins are ubiquitous, members of the Rab3 family are enriched in regulated-secretion-competent cells (11, 12). They are comprised of four isoforms (Rab3A, -B, -C, and -D). Rab3A, the best studied family member is abundantly expressed in brain and neuroendocrine cells. Absence of Rab3A in knock-out mice led to an enhancement of neurotransmitter release (21). Rab3A appeared to act at a late step as the pool of fusion-competent vesicles was unchanged. Its absence also interfered specifically with calcium-regulated fusion as triggering via a calcium-independent stimulus was not affected. Similar conclusions for the calcium-dependent action of Rab3 have been drawn from studies in adrenal chromaffin cells and Aplysia cholinergic neurons (22, 26). In mast cells, the predominant isoform is Rab3D, although Rab3A and Rab3B have also been detected (16, 27, 28). Overexpression of WT Rab3D inhibited Fcepsilon RI-triggered degranulation, an effect that was enhanced with preferentially GTP-bound mutants (16, 17).

Several Rab3 effectors have been described. Some, like calmodulin (29, 30), Rabphilin (31), Noc2 (32), or RIM (33), may be components of the calcium-dependent mechanism of exocytosis. However, a molecular understanding of their function in conjunction with Rab3 has not been achieved. In the present study we report the discovery of a Rab3D-associated kinase activity in RBL-2H3 mast cells. The activity or possibly the association of this kinase, named here Rak3D, was calcium regulated. Rak3D specifically phosphorylates syntaxin 4 thus decreasing its capacity to bind SNAP23. Therefore, this kinase may provide the link between Rab3D and the calcium dependence of SNARE complex formation in regulated-secretion competent cells.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Cultures and Transfections-- RBL-2H3, COS-7, and C57 cells (kindly provided by Dr. Dastych, International Institute of Molecular and Cell Biology, Poland) were maintained in Dulbecco's modified Eagle's medium-Glutamax medium (Life Technologies, Inc., Eragny, France) supplemented with 10% fetal bovine serum, 100 IU/ml penicillin G, and 100 µg/ml streptomycin (Life Technologies, Inc.) at 37 °C in a humidified 5% CO2 incubator. COS-7 cells were transfected by electroporation with 30 µg of Rab3A-SRalpha neo, Rab3D-SRalpha neo, and Sralpha neo vectors, as previously described (16). Cells were harvested 48 h later and processed for immunoprecipitation.

Antibodies and Other Reagents-- Anti-dinitrophenyl (DNP)-specific immunoglobulin E (IgE), rabbit anti-syk antibodies and affinity purified rabbit antibodies to Rab3D, syntaxin 4, and glutathione S-transferase (GST) have been described (14, 16, 34). Rabbit anti-syntaxin 4 was also purchased from Alomone Labs (Jerusalem, Israel). F(ab')2 fragment of peroxidase-conjugated anti-rabbit and normal rabbit IgG were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA). The pharmacological agents 4alpha -phorbol 12-myristate 13-acetate (PMA), wortmannin, EGTA, the kinase substrates myelin basic protein (MBP) and enolase, glutathione-Sepharose beads, as well as dinitrophenyl-human serum albumin (DNP-HSA) were purchased from Sigma. Ionomycin and bisindolylmaleimide I were obtained from Calbiochem (San Diego, CA). Protein A beads were from Amersham Pharmacia Biotech (Orsay, France).

Cell Stimulation and Immunoprecipitation-- RBL-2H3 cells were either harvested by trypsinization or left adherent. For stimulation experiments, RBL-2H3 or C57 mast cells were sensitized at 1-2.5 × 106 cells/ml with DNP-specific-IgE (1:200) in complete medium containing 20 mM Hepes, pH 7.3, for 1 h at 37 °C. After a washing step, cells were resuspended in complete medium, 20 mM Hepes, pH 7.3, and stimulated at 37 °C with 100 ng/ml DNP-HSA. The reaction was stopped by adding an excess of ice-cold phosphate-buffered saline. Cells were solubilized in lysis buffer (25 mM Pipes, pH 7.3, 150 mM NaCl, 5 mM KCl, 5 mM MgCl2, 1% Triton X-100, 1 mM sodium orthovanadate (Sigma), 1000 units/ml aprotinin (Sigma), 10 µg/ml pepstatin, 20 µg/ml leupeptin, 2 µM 4-(2-aminoethyl)benzenesulfonyl fluoride (all from Alexis Inc., San Diego CA) at 5 × 107 cells/ml (nonadherent cells) or by directly adding 1 ml of lysis buffer to adherent cells before harvesting them by scraping. Postnuclear supernatants were prepared by centrifugation at 15,000 × g for 30 min and added to 5 µg of anti-Rab3D antibody or normal rabbit IgG prebound to protein A-Sepharose beads and immunoprecipitated for 2 h at 4 °C.

In Vitro Immune Complex Kinase Assay (IVK)-- Immunoprecipitations were performed as above and washed additionally two times in kinase buffer (25 mM Pipes, pH 7.3, 150 mM NaCl, 5 mM KCl, 5 mM MnCl2, 5 mM MgCl2, 0.25% Triton X-100). IVK was performed in 50 µl of kinase buffer containing 10 µCi of [gamma -32P]ATP. Beads were washed two times and eluted in 2 × SDS sample buffer. When exogenous substrates were added, the reaction mixture was incubated in the presence of 10 µM substrate and following the IVK the total mixture was resolved after addition of SDS sample buffer without a further washing step. Quantitation of phosphorylated species was carried out on a PhosphorImager (Molecular Dynamics) using ImageQuant software.

In-gel Kinase Assay (IGKA)-- Anti-Rab3D or normal rabbit IgG immunoprecipitates were electrophoresed in a SDS-polyacrylamide gel containing MBP (0.5 mg/ml). IGKA was performed as described (35). Briefly, following electrophoresis, SDS was removed from the gel by repeated washings in 50 mM Tris-HCl, pH 8, containing 20% propanol-2. Proteins were denaturated in M urea 1 h at room temperature and renaturated overnight in 50 mM Tris-HCl, pH 8, containing 5 mM beta -mercaptoethanol and 0.04% Tween 20. The kinase assay was carried out by incubating the gel for 1 h at room temperature in kinase buffer containing a mixture of 20 µM ATP and 200 µCi of [gamma -32P]ATP. The gel was washed with a 5% trichloroacetic acid solution containing 1% sodium pyrophosphate and analyzed on a PhosphorImager.

Immunoblotting-- Proteins resolved on SDS-PAGE were transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany) and blocked by incubation in Tris-buffered saline containing 0.1% Tween 20 and 5% nonfat dry milk. Blots were then incubated for 1 h at room temperature with primary antibodies (anti-Rab3D at 1 µg/ml and anti-syntaxin 4 at 1/600 dilution). After several washes, peroxidase-labeled anti-rabbit IgGs (1:30,000 dilution) were used as secondary antibodies and incubated for 1 h at room temperature. The blots were developed using the enhanced chemiluminescence assay (Amersham Pharmacia Biotech).

Assay of beta -Hexosaminidase Secretion-- Granule secretion of the marker beta -hexosaminidase in the presence of pharmacological agents was analyzed as previously described (16). Pharmacological agents were added 15 min before stimulation and were kept during the 30-min stimulation period. The net percent inhibition was calculated in comparison to cells incubated in the presence of vehicle only.

Recombinant Proteins-- The cytoplasmic domains of rat syntaxin 24-265, syntaxin 34-263, and syntaxin 44-273 were expressed as GST fusion proteins using the pGEX-2TK vector (Amersham Pharmacia Biotech) and purified as described (14). Thrombin (Roche Molecular Biochemicals, Meylan, France) was used to cleave GST from soluble recombinant syntaxin 4. Recombinant human GST-SNAP23 was a gift of Thierry Galli (Institut Curie, Paris, France). Deletion mutants of syntaxin 4 were generated by polymerase chain reaction amplification to obtain Ha- (aa 4-68), Ha/Hb- (aa 4-114), and Ha/Hb/Hc- (aa 4-166) domains fused to GST.

In Vitro Binding Assay-- Soluble recombinant syntaxin 4 (10 µM) was phosphorylated in an IVK by Rak3D present in anti-Rab3D immunoprecipitates (107 cell equivalents). For binding to recombinant GST-SNAP23, soluble phosphorylated S4 (0.3 µM) was mixed in 300 µl of kinase buffer with glutathione-Sepharose beads containing 2 µM GST-SNAP23. The mixture was incubated 2 h at 4 °C with end-over-end rotation. Beads were centifuged and the supernatant (unbound syntaxin 4) was recovered and an equal amount of 2 × SDS sample buffer was added. Beads were washed twice with 1 ml of kinase buffer and 60 µl of sample buffer was added to recover bound syntaxin 4. Samples (bound and free syntaxin 4) were boiled for 3 min and equal amounts of protein were simultaneously resolved on two separate SDS-PAGE. Gels were processed for PhosphorImager analysis or immunoblotting with anti-syntaxin 4 antibody. Quantitation of phosphorylated and immunoblotted syntaxin 4 species was carried out using ImageQuant and NIH Image software, respectively. No binding was detectable to two other GST fusion proteins (GST-VAMP3 and GST-VAMP8) in control experiments.

In Vivo Labeling with [32P]Orthophosphate-- RBL-2H3 cells were treated as described (36). Briefly, 2 × 106 RBL-2H3 cells were incubated in phosphate-free medium for 3 h at 37 °C before addition of 1 µg/ml IgE for 1 h at 37 °C, then labeled with 330 µCi/ml [32P]orthophosphate for 3 h at 37 °C. Cells were washed with phosphate-free medium and stimulated with 100 ng/ml DNP-HSA for 5 min or left unstimulated. Ice-cold phosphate-buffered saline was added to stop stimulation and cells were lysed as described above. Syntaxin 4 and p72syk were immunoprecipitated from stimulated and unstimulated cells. After separation by SDS-PAGE and transfer onto a nitrocelullose filter, the membrane was autoradiographed and subsequently blotted with anti-syntaxin 4.

Phosphoamino Acid Analysis-- Phosphoamino acid analysis was carried out according to a published procedure (37). Briefly, Rab3D was immunoprecipitated and proteins were subjected to an IVK. The sample was run on SDS-PAGE and transferred onto a polyvinylidene difluoride membrane (HybondTM, Amersham Pharmacia Biotech). After a short autoradiography the portion corresponding to labeled species was excised. Bound protein was hydrolyzed in 6 M HCl for 1 h at 110 °C. The hydrolysate was dried, washed, and redissolved in acetic acid/pyridine/water (10:1:189, v:v:v). Phosphoserine, phosphothreonine, and phosphotyrosine standards (3 µg of each) were dissolved in 2 µl of acetic acid/pyridine buffer. The phosphoamino acids were separated at 1600 V for 20 min on a cellulose TLC in the same buffer used to dissolve samples. Unlabeled phosphoamino acid standards were detected with ninhydrin and labeled amino acids were visualized by autoradiography.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A Ser/Thr Kinase Is Associated with Rab3D in RBL-2H3 Cells-- Several functional links between protein kinases and small GTPases have been demonstrated making the search for protein kinases as potential effectors of Rab3D particularly important. To identify such a putative protein kinase we first examined whether the antibody we generated to the Rab3D carboxyl-terminal divergent region could specifically immunoprecipitate the Rab3D isoform, as both Rab3A and Rab3D are expressed in RBL-2H3, the mast cell line used in these studies. COS-7 cells were transfected with cDNAs encoding Rab3A, Rab3D, or the empty expression vector. Cell lysates were prepared and proteins were immunoprecipitated and immunoblotted using the anti-Rab3D antibody. As shown in Fig. 1A, a band corresponding to the expected molecular mass of 27 kDa was only detected in the Rab3D-transfected cells demonstrating that our antibody could indeed immunoprecipitate Rab3D in a specific manner. We next examined whether immobilized Rab3D was associated with a protein kinase activity by performing an IVK. A phosphorylated molecular species of about 130 kDa (pp130) was consistently detected in anti-Rab3D immunoprecipitates but not in those immunoprecipitates where normal rabbit IgG was used (Fig. 1B). To determine whether this phosphoprotein could represent a kinase, we first analyzed whether the kinase activity associated with Rab3D was able to phosphorylate enolase and MBP, which are generic substrates for protein tyrosine and Ser/Thr kinases, respectively. Fig. 2A shows that MBP was strongly phosphorylated in this assay while enolase remained unphosphorylated suggesting that the identified kinase activity corresponds to a Ser/Thr kinase. This was further confirmed by direct phosphoamino acid analysis that revealed that pp130 is phosphorylated on Ser/Thr residues but not on Tyr (Fig. 2B). The MBP protein was then used as a substrate in an IGKA to directly assay whether pp130 has by itself kinase activity. Fig. 2C shows the phosphorylated band that could be detected at a molecular mass of around 130 kDa. This suggests that the pp130 protein has itself kinase activity. Although this kinase activity appeared to be weak, when compared with IVK, denaturation, and renaturation of the kinase could likely affect the fraction of active kinase remaining in the IGKA. Indeed, as stronger exposures revealed a background activity in lanes of control IgG we quantitated the difference to Rab3D immunoprecipitates using PhosphorImager analysis, which was found to be more than 7-fold (see figure legend). Taken together, these results indicate that a Ser/Thr kinase of ~130 kDa is associated with Rab3D that we refer to in the following as Rak3D.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 1.   Presence of a kinase activity in Rab3D immunoprecipitates. A, specificity of an antibody to Rab3D. Proteins from lysates of COS-7 cells transfected with empty, Rab3A- or Rab3D-containing SRalpha neo vector were immunoprecipitated with anti-Rab3D, resolved on 12% SDS-PAGE, transferred to nitrocellulose, and probed with anti-Rab3D. The arrow indicates a specific band corresponding to the expected molecular weight for Rab3D. B, a kinase activity is associated with Rab3D immunoprecipitates (IP). Proteins from lysates of resting RBL-2H3 cells (107 cells/sample) were immunoprecipitated with anti-Rab3D or normal rabbit IgG (rIgG) and subjected to an IVK in the presence of [gamma -32P]ATP. After washing, labeled proteins were resolved on a 10% SDS-PAGE, and analyzed using a PhosphorImager. The arrow indicates the presence of a Rab3D-associated 130-kDa phosphoprotein (pp130).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Characterization of Rab3D-associated kinase activity. A, phosphorylation of the Ser/Thr kinase substrate MBP, but not the tyrosine kinase substrate enolase by a Rab3D-associated kinase activity. Rab3D was immunoprecipitated from lysates of resting RBL-2H3 cells (107 cells/sample). An IVK was performed in the presence of 10 µM enolase or MBP and [gamma -32P]ATP. Phosphorylated proteins were resolved on 15% SDS-PAGE and analyzed on a PhosphorImager. B, pp130 is phosphorylated on Ser/Thr residues. Following IVK pp130 was subjected to phosphoamino acid analysis (PAA) as described under "Experimental Procedures." Labeled amino acids were visualized by autoradiography and compared with phosphoamino acid standards represented schematically. C, identification of the pp130 as the Rab3D-associated kinase (Rak3D) activity. Anti-Rab3D or normal rabbit IgG immunoprecipitates from lysates of resting RBL-2H3 cells were resolved on 10% SDS-PAGE containing 10 µM MBP as a substrate. Separated proteins in the gel were renaturated as described under "Experimental Procedures" and subjected to an IGKA in the presence of 20 µM ATP and 200 µCi of [gamma -32P]ATP. A labeled 130-kDa phosphoprotein (arrow) was detected after PhosphorImager analysis. Quantitation of the optical densities (arbitrary units) between normal IgG and anti-Rab3D in the p130 area by PhosphorImager analysis revealed a 7.4 ± 2.3 (mean ± S.D.) difference in three independent experiments (experiment 1 = 10.0; experiment 2 = 5.8, and experiment 3 = 6.8).

Fcepsilon RI-dependent Modulation of Rak3D-- Rab3D has been shown to inhibit mast cell degranulation stimulated via Fcepsilon RI (16, 17). As the signaling pathways between the initial stimulation event and Rab3D are presently unknown we wished to analyze whether receptor triggering could affect the kinase activity associated with Rab3D. IgE-sensitized RBL-2H3 cells were challenged with antigen for varying times and p130 autophosphorylation was determined. Fig. 3A shows a representative kinetic experiment as well as a quantitative analysis corresponding to several experiments. The highest level of p130 autophosphorylation was observed in resting cells. Interestingly, Fcepsilon RI engagement for a short time (3 min) led to a decrease in p130 autophosphorylation, which then progressively increased again over longer periods of stimulation. Similar results were obtained when we tested adherent RBL-2H3 cells or C57 mast cells that grow in suspension thus excluding an effect of trypsin treatment (data not shown). The capacity of the kinase to transphosphorylate MBP is similarly down-modulated by Fcepsilon RI engagement (Fig. 3B). To examine whether the observed modulation of Rak3D was an early receptor-dependent event, we stimulated cells with the calcium ionophore, iononomycin, and the PKC activator, PMA, to bypass receptor-proximal events. The experiment shown in Fig. 3C revealed that stimulation by PMA/ionomycin reproduced the kinetics observed upon stimulation through Fcepsilon RI suggesting that the observed modulation of Rak3D is downstream of PKC- and calcium-activated signals. PMA alone did not reproduce the same kinetics (data not shown) indicating a calcium regulatory step. An additional approach based on the use of pharmacological inhibitors was undertaken to examine potential signals involved in the modulation of Rak3D. RBL-2H3 cells were incubated in the presence of EGTA, which blocks calcium influx, bisindolylmaleimide I, a broad spectrum inhibitor of PKC (38), and wortmannin, a PI 3-kinase inhibitor (39). As shown in Fig. 3D, only EGTA treatment abolished the observed decrease of detectable Rak3D activity following Fcepsilon RI triggering although all pharmacological agents were nonpermissive for degranulation at the applied doses. Altogether, these results are in favor of a calcium-dependent modulation of Rak3D.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 3.   Rak3D activity is Fcepsilon RI-stimulation-dependent. Fcepsilon RI-modulation of Rak3D activity as revealed by the phosphorylation of p130 (A) and MBP (B). IgE-sensitized RBL-2H3 cells were stimulated with DNP-HSA (100 ng/ml) for the indicated times. Proteins in cell lysates were immunoprecipitated with either anti-Rab3D or rabbit IgG as indicated and subjected to an IVK in the presence of [gamma -32P]ATP (A) or 10 µM MPB and [gamma -32P]ATP (B). Phosphorylated proteins were separated on 10% SDS-PAGE and analyzed on a PhosphorImager. Equal loading was verified by immunoblotting with anti-Rab3D. The histogram in A represents a quantitative analysis of the relative pp130 levels from six independent experiments (mean ± S.E.). C, Rak3D activity is regulated downstream of calcium- and PKC-activated signals. RBL-2H3 cells were stimulated with a combination of PMA (20 nM) and ionomycin (1 µM) for the indicated times. Proteins from cell lysates were immunoprecipitated with anti-Rab3D and subjected to an IVK in the presence of [gamma -32P]ATP. A PhosphorImager analysis of the 130-kDa Rak3D activity is shown. Equal loading was verified by immunoblotting with anti-Rab3D. D, Rak3D activity is regulated by calcium, but not PKC or PI 3-kinase. IgE-sensitized RBL-2H3 cells were preincubated in the presence of 5 mM EGTA, 2 µM bisindolylmaleimide I, and 100 nM wortmannin. Cells were stimulated with DNP-HSA (100 ng/ml) for the indicated times in the continuous presence of inhibitors. Cell lysates were prepared, subjected to an IVK, and Rak3D phosphorylation was analyzed as above. In parallel beta -hexosaminidase release was measured and percent inhibition (mean ± S.E.) was calculated as compared with cells incubated in the presence of vehicle. Data are from at least three independent experiments.

Rak3D Specifically Phosphorylates Syntaxin 4 in Its NH2-terminal Regulatory Domain-- One of the proposed roles for Rab3 proteins is the calcium-dependent regulation of membrane fusion. However, the molecular mechanisms are poorly understood. As we found that Rak3D was calcium-regulated it was of interest to determine whether it could directly phosphorylate SNARE proteins. An IVK was performed in the presence of GST fusion proteins containing the cytoplasmic domains of syntaxin 2, syntaxin 3, or syntaxin 4. All of these syntaxins had been previously shown to be phosphorylated by specific sets of kinases (40, 41). The results from a representative IVK in the presence of 10 µM substrate are shown in Fig. 4A. Surprisingly, these results revealed a unique specificity for Rak3D, in that it effectively phosphorylated GST-syntaxin 4 while not phosphorylating GST-syntaxin 2 or 3. Because of the specificity of Rak3D we tested a variety of other SNARE fusion proteins expressed in RBL-2H3 cells including GST-SNAP23, GST-VAMP2, GST-VAMP3, and GST-VAMP8. With the sole exception of syntaxin 4, all other tested proteins failed to be phosphorylated by Rak3D under the conditions used (data not shown). We also found that comparable to its autophosphorylation and the phosphorylation of the exogenous substrate MBP, the phosphorylation of GST-syntaxin 4 followed the same receptor-dependent kinetics, with a pronounced down-regulation at 3 min of stimulation (Fig. 4B). To shed some insight on its unusual specificity for syntaxin 4 we wished to determine the site of phosphorylation in syntaxin 4. We constructed a series of deletion mutants (Fig. 4C) that allowed examination of the various helices (Ha, Hb, and Hc) present in the NH2-terminal regulatory domain as well as the SNARE motif (H3 domain) as predicted from sequence alignment and the resolved crystal structure of syntaxin 1 (42) (Fig. 4C). Ten µM of the various deletion mutants were subjected to an IVK in the presence of Rak3D. Fig. 4C shows the phosphorylation pattern of the different deletion mutants as well as a quantitative PhosphorImager analysis summarizing several experiments. The results demonstrate that Rak3D is able to phosphorylate syntaxin 4 at more than one site in the NH2-terminal regulatory domain. Significant differences in relative amount of phosphorylation were observed for both Hb and Hc in the NH2-terminal regulatory domain. Sequence alignment comparisons among the three syntaxins suggest that Ser-78 could be one of the phosphorylated residues in Hb as it was the only serine or threonine residue which was absent in syntaxin 2 and 3. These data also corroborate our previous conclusion that Rak3D is a Ser/Thr kinase because tyrosine residues are not present in Hb. Several candidate residues that could account for specific phosphorylation of Hc in syntaxin 4 are Thr-120, Ser-143, and Ser-146, because these are absent in the corresponding syntaxin 2 and 3 sequences.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 4.   Rak3D specifically phosphorylates the Q SNARE syntaxin 4. A, syntaxin 4 is a specific substrate of Rak3D. Protein from lysates of resting RBL-2H3 cells (107 cells/sample) were immunoprecipitated with anti-Rab3D and subjected to an IVK in the presence of [gamma -32P]ATP and 10 µM GST-syntaxin 2 (GST-syn2), GST-syntaxin 3 (GST-syn3), or GST-syntaxin 4 (GST-syn4). Reaction products were resolved on 10% SDS-PAGE and analyzed using a PhosphorImager and Coomassie Blue staining. B, phosphorylation of GST-syntaxin 4 by Rak3D is Fcepsilon RI-regulated. IgE-sensitized RBL-2H3 cells were stimulated with DNP-HSA (100 ng/ml) for the indicated times. Proteins from cell lysates were immunoprecipitated with anti-Rab3D and subjected to an IVK in the presence of [gamma -32P]ATP and 10 µM GST-syntaxin 4 fusion protein. Phosphorylated proteins were resolved on 10% SDS-PAGE and analyzed using a PhosphorImager. C, Rak3D phosphorylates syntaxin 4 in Hb and Hc of the NH2-terminal regulatory domain. Proteins from lysates of resting RBL-2H3 cells (107 cells/sample) were immunoprecipitated with anti-Rab3D and subjected to an IVK in the presence of [gamma -32P]ATP and 10 µM GST-syntaxin 4 (GST-syntaxin 4) or the syntaxin 4 deletion mutants (GST-Ha, GST-Ha/Hb, and GST-Ha/Hb/Hc). The relative location of each mutation is show in the schematic representation of syntaxin 4 modeled after the structure of syntaxin 1. The histogram shows a quantitative determination of relative phosphorylation levels for the different mutants (mean ± S.E.) from five independent experiments using ImageQuant Software. The asterisk indicates statistical significant differences between mutants (p < 0.05, Wilcoxon test).

Syntaxin 4 Phosphorylation by Rak3D Affects Its Interaction with the t-SNARE SNAP23-- Although not located in the SNARE motif, phosphorylation in the NH2-terminal regulatory domain of syntaxin 4 may indirectly affect SNARE assembly due to induced conformational changes or steric hindrance. We therefore assessed whether phosphorylation by Rak3D could affect binding of syntaxin 4 to one of its t-SNARE partners SNAP23. We designed a quantitative assay to evaluate phosphorylated syntaxin 4 binding to SNAP23, taking into account that only a small amount of added syntaxin 4 becomes phosphorylated in the IVK. Indeed, preliminary experiments established that less than 1% of the syntaxin 4 used in the kinase reaction was phosphorylated (under limiting concentrations of Rak3D and [gamma -32P]ATP). The assay was designed to measure total syntaxin 4 or phosphorylated syntaxin 4 binding to SNAP23. Recombinant soluble syntaxin 4 devoid of GST was incubated with Rak3D to induce phosphorylation. An aliquot of the reaction was incubated with GST-SNAP23 prebound to glutathion-Sepharose. The bound and unbound syntaxin 4 was determined by immunoblotting (total syntaxin 4) and by PhosphorImager analysis (phosphorylated syntaxin 4). Fig. 5 shows the results of a representative experiment and Table I summarizes the data obtained from five independent experiments where different concentrations of syntaxin 4 were added to the binding reaction. Based on these results we determined that the binding of phosphorylated syntaxin 4 to SNAP23 was inhibited by 70.6 ± 13.1% (mean ± S.E.). This demonstrates that the phosphorylation of syntaxin 4 by Rak3D affects its ability to assemble with SNAP23.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 5.   Phosphorylation of syntaxin 4 by Rak3D inhibits binding to SNAP23. Ten µM soluble recombinant syntaxin 4 was used in an IVK with immunoprecipitated Rab3D (107 cells). 0.3 µM of the phosphorylated protein was incubated with 1.5 µM GST-SNAP23 bound to gutathione-Sepharose beads for 1 h at 4 °C. Proteins in the supernatant and bound materials were resolved by SDS-PAGE and analyzed using a PhosphorImager (phospho syn4) or by immunoblotting using a syntaxin 4-specific antibody (total syn4). Data presented correspond to experiment 3 in Table I.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effect of syntaxin 4 phosphorylation by Rak3D on SNAP23 binding

Syntaxin 4 Is Phosphorylated in RBL-2H3 Cells-- We finally asked whether syntaxin 4 could be phosphorylated in vivo in resting cells and whether this phosphorylation decreased as observed in our in vitro experiments. RBL-2H3 cells were labeled with [32P]orthophosphate and syntaxin 4 was immunoprecipitated from resting and stimulated cells. Experiments shown in Fig. 6 revealed that syntaxin 4 is indeed phosphorylated in resting cells in agreement with our in vitro data. Its overall phosphorylation status, however, did not seem dramatically affected by receptor engagement although stimulation was successful as indicated by the increased phosphorylation of syk tyrosine kinase.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 6.   Syntaxin 4 is phosphorylated in RBL-2H3 mast cells. IgE-sensitized RBL-2H3 cells were labeled with 330 µCi/ml 32P stimulated with 100 ng/ml DNP-HSA for 5 min or were left unstimulated. Labeled proteins were immunoprecipitated using specific antibodies to syntaxin 4 and Syk tyrosine kinase and analyzed by autoradiography after migration on SDS-PAGE and transfer onto a nitrocellulose membrane. The membrane was subsequently blotted with anti-syntaxin 4 antibody. Labeled immunoprecipitated species are specific as they cannot be detected in the respective immunoprecipitates performed with the other antibody.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Rab3 GTPases function in regulated-secretion competent cells by limiting calcium-triggered membrane fusion mediated by SNARE proteins (12, 21, 22). The relationship between the calcium signal obtained after cell stimulation and Rab3 action remains poorly understood. Nevertheless, recent evidence from studies both in yeast and mammalian cells indicates that protein phosphorylation and dephosphorylation represents an important mechanism that regulates SNARE assembly (40, 41, 43-45). Furthermore, it was demonstrated that small G proteins from the Ras, Rho, and Rab families function together with protein kinases to facilitate their actions (46-48). A well known example is the Ras-dependent recruitment of Raf leading to the activation of the mitogen-activated protein kinase cascade and gene regulation (46). This prompted us to search for IgE-triggered phosphorylation events that could be associated with Rab3D, a regulator of exocytosis in RBL-2H3 mast cells.

Using IVK we discovered a 130-kDa Ser/Thr-phosphorylated protein that was consistently co-immunoprecipitated with Rab3D. After performing an in-gel kinase assay in the presence of the generic substrate MBP we found that a protein in this molecular weight range was the unique Rab3D-associated protein that revealed kinase activity. This suggests that pp130 represents by itself a Ser/Thr kinase that we have termed here Rak3D. The activity was maximal in unstimulated cells and decreased dramatically after Fcepsilon RI stimulation. The kinetic was reproduced after stimulation with PMA/ionomycin indicating that the kinase is regulated by a late signaling step independent of receptor-proximal events. Use of pharmacological agents like wortmannin, bisindolylmaleimide I, and EGTA, which block degranulation by different mechanisms, revealed that only EGTA inhibited the observed decrease demonstrating the critical role of calcium influx in regulating Rak3D. Although evidence exists in several systems that the action of Rab proteins requires activation of PI 3-kinase, by notably providing membrane attachments sites for effectors (18), our data using wortmannin suggest that PI 3-kinase is not necessary for regulation of Rak3D. Similarly, PKC activation, which is important in mast cell secretion (49), did not seem to regulate Rak3D, as inhibition with bisindolylmaleimide I had no effect on Rak3D.

At this point we are unable to explain the relationship between the kinase and the nucleotide-bound state of Rab3D. Attempts to isolate Rak3D using GTP or GDP-bound recombinant GST-Rab3D fusion proteins have been unsuccessful,3 suggesting that the granule membrane-localized Rab3D (28) most likely requires lipid modification for this interaction, as is the case for several Rab3 effectors (29, 50-52). Similarly, when we tried to immunoprecipitate Rab3D from cells stably transfected with GTP-bound mutant forms (N135I and Q81L) no changes were observed in the Fcepsilon RI-dependent downmodulation.3 The easiest explanation would be that the association of the kinase may not necessarily depend on the nucleotide-bound state of Rab3D. In this context, it has been recently demonstrated that lipid-modified Rab3A can bind to calcium/calmodulin (Ca2+/CaM) in the presence of either GDP or GTP via a Rab3-conserved basic amino acid sequence (29). This interaction caused the dissociation of Rab3A from its target membrane (29, 30). Thus, it is possible that Fcepsilon RI engagement induces the dissociation of Rab3D from Rak3D by a similar calcium/CaM-dependent mechanism.

Although we have not formally demonstrated that the pp130 protein (Rak3D) is the kinase responsible for phosphorylation of the t-SNARE syntaxin 4 we found that the activity present in Rab3D immunoprecipitates specifically phosphorylates this t-SNARE and the activity was similarly down-regulated after stimulation. Thus, as this was the only identifiable activity in Rab3D immunoprecipitates it is likely that pp130 represents the syntaxin 4 kinase. The t-SNAREs syntaxin 2 and 3 were not phosphorylated, although the latter clearly have been shown to be substrates of different kinases (40, 41). Likewise, we did not detect phosphorylation of other SNARE proteins expressed in RBL-2H3 cells by Rak3D, including the t-SNARE SNAP23 or several v-SNAREs (VAMP2, VAMP3, and VAMP8). Thus, this unique selectivity for syntaxin 4 suggests an important role for Rak3D in regulating SNARE complex assembly. Interestingly, the plasma-membrane localized syntaxin 4 (53, 54) was recently demonstrated to be a key component of the fusion complex in mast cells and a variety of other cells (14, 55, 56). Using a series of deletion mutants we established that syntaxin 4 becomes phosphorylated at two different helices (Hb and Hc) in the NH2-terminal regulatory domain (42, 57). Comparison of sequence alignments with syntaxin 2 and 3 suggest several phosphorylatable residues (Ser-78, Thr-120, Ser-143, and Ser-146) that are solvent accessible in the homologous syntaxin 1 structure (42). However, it appears that some of these sites (Ser-143 and Ser-146) may become inaccessible when another regulator, the Munc18-3 protein is bound to syntaxin 4 (58), whereas Thr-120 upon phosphorylation could affect the interaction with the COOH-terminal SNARE motif. Phosphorylation of syntaxins in the regulatory domain is not unique to syntaxin 4 (40, 41). Syntaxin 1 was shown to be phosphorylated in the regulatory domain, but unlike syntaxin 4 its phosphorylation is located close to the NH2 terminus before the Ha domain (59).

Our work also revealed that phosphorylation by Rak3D results in a decrease of syntaxin 4 binding to its t-SNARE partner SNAP23. Several arguments suggest that a phosphorylation-dependent mechanism of SNARE complex assembly might be relevant in mast cell exocytosis. (i) Clearly, the down-modulation of Rak3D can be observed in intact cells and this correlates with the initiation of secretion (16). (ii) In vivo labeling of RBL-2H3 cells with [32P]orthophosphate has shown that syntaxin 4 is indeed phosphorylated in unstimulated cells. (iii) There is also evidence that secretion in mast cells is coupled to dephosphorylation by the protein phosphatase 2A, which is recruited to the plasma membrane following Fcepsilon RI triggering (60). Although the molecular targets of this phosphatase recruitment are not known it could serve to dephosphorylate syntaxin 4 thereby facilitating membrane fusion. In our in vivo labeling experiments we were, however, unable to observe an apparent change in the syntaxin 4 phosphorylation status following stimulation. A probable explanation may be that dephosphorylation could concern only a small fraction of phosphorylated syntaxin 4 molecules at a given time. Previous analysis of SNARE-mediated-fusion processes in yeast have indeed suggested that regulatory mechanisms occur locally, are transient in nature, and include only a small proportion (<2%) of all SNARE molecules (61). An additional reason may be that syntaxin 4 can be phosphorylated at multiple sites and that dephosphorylation at a precise residue might occur following stimulation and be functionally important without dramatically affecting the overall phosphorylation level of the total cellular protein.

How can these studies be interpreted in the context of the proposed differential localization of Rab3D and syntaxin 4? Indeed, in unstimulated cells, syntaxin 4 is plasma membrane localized while Rab3D is localized to the granule compartment (28, 53, 54). It is possible that the kinase is only active toward syntaxin 4 when mediator-containing granules become tethered at the plasma membrane. Thus, the tethered granule membrane is actively restricted from fusing with the plasma membrane by Rak3D-dependent phosphorylation of syntaxin 4 (29). After stimulation Rab3D is found at the plasma membrane (28) possibly as a Rab3D-Ca2+·CaM complex that continues to control exocytosis, as previously suggested (30).

In conclusion, mast cells tethering of granules to the plasma membrane has been observed (2, 3). Moreover, the compound exocytosis observed in mast cells suggests that tethered granules are fully competent for fusion as they are first to release their content upon encountering an appropriate stimulus. Therefore, we suggest that phosphorylation of syntaxin 4 in resting mast cells by Rak3D represents one of the mechanisms that limits the assembly of closely tethered SNARE proteins in resting cells. Cell activation and intracellular calcium increases may counteract this Rab3D/phosphorylation-dependent fusion clamp. Preliminary analysis suggest that Rak3D can be detected in other secretion-competent tissues such as rat adipocytes and rat pancreas.3 However, the identity of the kinase remains as of yet unknown. Inhibitors of PKC as well as a variety of other kinases (CaMKII, casein kinase, myosin light chain kinase, and protein kinase A) did not affect Rak3D activity in our IVK.3 This of course differs from the PKC-dependent syntaxin 4 phosphorylation, observed in activated human platelets (62) and thus we are actively engaged in the identification of this kinase.

    Acknowlegments

We thank Dr. C. Guérin-Marchand and Dr. M. Roa for discussions and advice. We are grateful to Dr. M. Benhamou for critical reading of the manuscript, R. Peronet for help in preparing polyclonal antibodies, and Valentino Paravinci for help in [32P] in vivo labeling. We also thank Dr. P. Alzari for insights on the potential phosphorylation sites in the homologues syntaxin 1 crystal structure and Vincenzo Di Bartolo for help with the phosphamino acid analysis.

    FOOTNOTES

* This work was supported in part by the Institut Pasteur.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by a PRAXIS XXI fellowship (Ministério da Ciência e Tecnologia, Portugal).

|| To whom correspondence should be addressed: Institut Pasteur, Unité d'Immuno-Allergie, 25-28 rue du Dr. Roux, 75724 Paris Cedex 15. Tel.: 33-1-40-61-32-64; Fax: 33-1-40-61-31-60; E-mail: ublank@pasteur.fr.

Published, JBC Papers in Press, September 12, 2001, DOI 10.1074/jbc.M103527200

2 SNAREs were originally divided into t-SNAREs and v-SNAREs according to their target or vesicle membrane localization. A second terminology has been proposed to avoid ambiguity in the case of homotypic membrane fusion. Thus, t-SNAREs have been reclassified as Q-SNAREs (Glu-containing SNARES) and R-SNARES (Arg-containing SNAREs), based on the identity of a highly conserved residue.

3 I. Pombo and U. Blank, unpublished data.

    ABBREVIATIONS

The abbreviations used are: Fcepsilon RI, type I high affinity IgE receptor; Ca2+/CaM, calcium/calmodulin; CaMKII, Ca2+/calmodulin-dependent protein kinase II; DNP, dinitrophenyl; GST, glutathione S-transferase; HSA, human serum albumin; IGKA, in-gel kinase assay; IVK, in vitro immune complex kinase assay; MBP, myelin basic protein; PAGE, polyacrylamide gel electrophoresis; PI 3-kinase, phosphatidylinositol 3-kinase; PMA, phorbol 12-myristate 13-acetate; Rak3D, Rab3D associated kinase; RBL-2H3, rat basophilic leukemia cells; SNAP23 or 25, synaptosome-associated protein of 23 kDa or 25 kDa; SNARE, soluble N-ethylmaleimide attachment protein receptor; Syn, syntaxin; VAMP, vesicle-associated membrane protein; Pipes, 1,4-piperazinediethanesulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Galli, S., and Lantz, C. S. (1998) in Fundamental Immunology (Paul, W., ed), 4th Ed. , pp. 1127-1174, Raven Press, New York
2. Röhlich, P., Anderson, P., and Uvnäs, B. (1971) J. Cell Biol. 51, 465-483
3. Alvarez De Toledo, G., Fernandez-Chacon, R., and Fernandez, J. (1993) Nature 363, 554-558[CrossRef][Medline] [Order article via Infotrieve]
4. Kim, T., Eddlestone, G., Mahmoud, S., Kuchtey, J., and Fewtrell, C. (1997) J. Biol. Chem. 272, 31225-31229[Abstract/Free Full Text]
5. Kinet, J. P. (1999) Annu. Rev. Immunol. 17, 931-972[CrossRef][Medline] [Order article via Infotrieve]
6. Williams, R. M., and Webb, W. W. (2000) J. Cell Sci. 113, 3839-3850[Abstract]
7. Söllner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve]
8. Jahn, R., and Südhof, T. C. (1999) Annu. Rev. Biochem. 68, 863-911[CrossRef][Medline] [Order article via Infotrieve]
9. Bock, J. B., Matern, H. T., Peden, A. A., and Scheller, R. H. (2001) Nature 409, 839-841[CrossRef][Medline] [Order article via Infotrieve]
10. Chen, Y. A., and Scheller, R. H. (2001) Nat. Rev. Mol. Cell. Biol. 2, 98-106[CrossRef][Medline] [Order article via Infotrieve]
11. Gonzalez, L., Jr., and Scheller, R. H. (1999) Cell 96, 755-758[CrossRef][Medline] [Order article via Infotrieve]
12. Darchen, F., and Goud, B. (2000) Biochimie 82, 375-384[Medline] [Order article via Infotrieve]
13. Guo, Z., Turner, C., and Castle, D. (1998) Cell 94, 537-548[CrossRef][Medline] [Order article via Infotrieve]
14. Paumet, F., Le Mao, J., Martin, S., Galli, T., David, B., Blank, U., and Roa, M. (2000) J. Immunol. 164, 5850-5857[Abstract/Free Full Text]
15. Baram, D., Adachi, R., Medalia, O., Tuvim, M., Dickey, B. F., Mekori, Y. A., and Sagi-Eisenberg, R. (1999) J. Exp. Med. 189, 1649-1658[Abstract/Free Full Text]
16. Roa, M., Paumet, F., Le Mao, J., David, B., and Blank, U. (1997) J. Immunol. 159, 2815-2823[Abstract]
17. Demo, S. D., Masuda, E., Rossi, A. B., Throndset, B. T., Gerard, A. L., Chan, E. H., Armstrong, R. J., Fox, B. P., Lorens, J. B., Payan, D. G., Scheller, R. H., and Fisher, J. M. (1999) Cytometry 36, 340-348[CrossRef][Medline] [Order article via Infotrieve]
18. Zerial, M., and McBride, H. (2001) Nat. Rev. Mol. Cell. Biol. 2, 107-117[CrossRef][Medline] [Order article via Infotrieve]
19. Takai, Y., Sasaki, T., and Matozaki, T. (2001) Physiol. Rev. 81, 153-208[Abstract/Free Full Text]
20. Waters, M. G., and Pfeffer, S. R. (1999) Curr. Opin. Cell Biol. 11, 453-459[CrossRef][Medline] [Order article via Infotrieve]
21. Geppert, M., Goda, Y., Stevens, C., and Südhof, T. (1997) Nature 387, 810-814[CrossRef][Medline] [Order article via Infotrieve]
22. Doussau, F., Clabecq, A., Henry, J. P., Darchen, F., and Poulain, B. (1998) J Neurosci. 18, 3147-3157[Abstract/Free Full Text]
23. Schimmoller, F., Simon, I., and Pfeffer, S. R. (1998) J. Biol. Chem. 273, 22161-22164[Free Full Text]
24. Nielsen, E., Severin, F., Backer, J. M., Hyman, A. A., and Zerial, M. (1999) Nat. Cell Biol. 1, 376-382[CrossRef][Medline] [Order article via Infotrieve]
25. Echard, A., Jollivet, F., Martinez, O., Lacapere, J. J., Rousselet, A., Janoueix-Lerosey, I., and Goud, B. (1998) Science 279, 580-585[Abstract/Free Full Text]
26. Johannes, L., Lledo, P. M., Chameau, P., Vincent, J. D., Henry, J. P., and Darchen, F. (1998) J. Neurochem. 71, 1127-1133[Medline] [Order article via Infotrieve]
27. Oberhauser, A., Balan, V., Fernandez-Badilla, C., and Fernandez, J. (1994) FEBS Lett. 339, 171-174[CrossRef][Medline] [Order article via Infotrieve]
28. Tuvim, M. J., Adachi, R., Chocano, J. F., Moore, R. H., Lampert, R. M., Zera, E., Romero, E., Knoll, B. J., and Dickey, B. F. (1999) Am. J. Resp. Cell Mol. Biol. 20, 79-89[Abstract/Free Full Text]
29. Park, J. B., Farnsworth, C. C., and Glomset, J. A. (1997) J. Biol. Chem. 272, 20857-20865[Abstract/Free Full Text]
30. Coppola, T., Perret-Menoud, V., Luthi, S., Farnsworth, C. C., Glomset, J. A., and Regazzi, R. (1999) EMBO J. 18, 5885-5891[CrossRef][Medline] [Order article via Infotrieve]
31. Yamaguchi, T., Shirataki, H., Kishida, S., Miyazaki, M., Nishikawa, J., Wada, K., Numata, S., Kaibuchi, K., and Takai, Y. (1993) J. Biol. Chem. 268, 27164-27170[Abstract/Free Full Text]
32. Haynes, L. P., Evans, G. J., Morgan, A., and Burgoyne, R. D. (2001) J. Biol. Chem. 276, 9726-9732[Abstract/Free Full Text]
33. Wang, Y., Okamoto, M., Schmitz, F., Hofmann, K., and Südhof, T. (1997) Nature 388, 593-598[CrossRef][Medline] [Order article via Infotrieve]
34. Duprez, V., Blank, U., Chretien, S., Gisselbrecht, S., and Mayeux, P. (1998) J. Biol. Chem. 273, 33985-33990[Abstract/Free Full Text]
35. Kameshita, I., and Fujisawa, H. (1989) Anal. Biochem. 183, 139-143[CrossRef][Medline] [Order article via Infotrieve]
36. Adamczewski, M., Paolini, R., and Kinet, J. P. (1992) J. Biol. Chem. 267, 18126-18132[Abstract/Free Full Text]
37. Ley, S. C., Davies, A. A., Druker, B., and Crumpton, M. J. (1991) Eur. J. Immunol. 21, 2203-2209[Medline] [Order article via Infotrieve]
38. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D., and Kirilovsky, J. (1991) J. Biol. Chem. 266, 15771-15781[Abstract/Free Full Text]
39. Yano, H., Nakanishi, S., Kimura, K., Hanai, N., Saitoh, Y., Fukui, Y., Nomomura, Y., and Matsuda, Y. (1993) J. Biol. Chem. 268, 25846-25856[Abstract/Free Full Text]
40. Foster, L. J., Yeung, B., Mohtashami, M., Ross, K., Trimble, W. S., and Klip, A. (1998) Biochemistry 37, 11089-11096[CrossRef][Medline] [Order article via Infotrieve]
41. Risinger, C., and Bennett, M. K. (1999) J. Neurochem. 72, 614-624[CrossRef][Medline] [Order article via Infotrieve]
42. Misura, K. M. S., Scheller, R. H., and Weis, W. I. (2000) Nature 404, 355-362[CrossRef][Medline] [Order article via Infotrieve]
43. Turner, K. M., Burgoyne, R. D., and Morgan, A. (1999) Trends Neurosci. 22, 459-464[CrossRef][Medline] [Order article via Infotrieve]
44. Marash, M., and Gerst, J. E. (2001) EMBO J. 20, 411-421[CrossRef][Medline] [Order article via Infotrieve]
45. Fujita, Y., Sasaki, T., Fukui, K., Kotani, H., Kimura, T., Hata, Y., Südhof, T., Scheller, R., and Takai, Y. (1996) J. Biol. Chem. 271, 7265-7268[Abstract/Free Full Text]
46. Marshall, M. S. (1995) FASEB J. 9, 1311-1318[Abstract]
47. Yasui, Y., Amano, M., Nagata, K., Inagaki, N., Nakamura, H., Saya, H., Kaibuchi, K., and Inagaki, M. (1998) J. Cell Biol. 143, 1249-1258[Abstract/Free Full Text]
48. Ren, M., Zeng, J., De Lemos-Chiarandini, C., Rosenfeld, M., Adesnik, M., and Sabatini, D. D. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5151-5155[Abstract/Free Full Text]
49. Nechushtan, H., Leitges, M., Cohen, C., Kay, G., and Razin, E. (2000) Blood 95, 1752-1757[Abstract/Free Full Text]
50. Fukui, K., Sasaki, T., Imazumi, K., Matsuura, Y., Nakanishi, H., and Takai, Y. (1997) J. Biol. Chem. 272, 4655-4658[Abstract/Free Full Text]
51. Wada, M., Nakanishi, H., Satoh, A., Hirano, H., Obaishi, H., Matsuura, Y., and Takai, Y. (1997) J. Biol. Chem. 272, 3875-3878[Abstract/Free Full Text]
52. Martincic, I., Peralta, M. E., and Ngsee, J. K. (1997) J. Biol. Chem. 272, 26991-26998[Abstract/Free Full Text]
53. Low, S. H., Chapin, S. J., Weimbs, T., Komuves, L. G., Bennett, M. K., and Mostov, K. E. (1996) Mol. Biol. Cell 7, 2007-2018[Abstract]
54. Hackam, D. J., Rotstein, O. D., Bennett, M. K., Klip, A., Grinstein, S., and Manolson, M. F. (1996) J. Immunol. 156, 4377-4383[Abstract]
55. Olson, A., Knight, J., and Pessin, J. (1997) Mol. Cell. Biol. 17, 2425-2435[Abstract]
56. Flaumenhaft, R., Croce, K., Chen, E., Furie, B., and Furie, B. C. (1999) J. Biol. Chem. 274, 2492-2501[Abstract/Free Full Text]
57. Dulubova, I., Sugita, S., Hill, S., Hosaka, M., Fernandez, I., Südhof, T. C., and Rizo, J. (1999) EMBO J. 18, 4372-4382[CrossRef][Medline] [Order article via Infotrieve]
58. Tellam, J., Macaulay, S., McIntosh, S., Hewish, D., Ward, C., and James, D. (1997) J. Biol. Chem. 272, 6179-6186[Abstract/Free Full Text]
59. Foletti, D. L., Lin, R., Finley, M. A., and Scheller, R. H. (2000) J. Neurosci. 20, 4535-4544[Abstract/Free Full Text]
60. Ludowyke, R. I., Holst, J., Mudge, L. M., and Sim, A. T. (2000) J. Biol. Chem. 275, 6144-6152[Abstract/Free Full Text]
61. Ungermann, C., Sato, K., and Wickner, W. (1998) Nature 396, 543-548[CrossRef][Medline] [Order article via Infotrieve]
62. Chung, S. H., Polgar, J., and Reed, G. L. (2000) J. Biol. Chem. 275, 25286-25291[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
Y. Suzuki, T. Yoshimaru, T. Inoue, and C. Ra
Mitochondrial Ca2+ flux is a critical determinant of the Ca2+ dependence of mast cell degranulation
J. Leukoc. Biol., March 1, 2006; 79(3): 508 - 518.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Hepp, N. Puri, A. C. Hohenstein, G. L. Crawford, S. W. Whiteheart, and P. A. Roche
Phosphorylation of SNAP-23 Regulates Exocytosis from Mast Cells
J. Biol. Chem., February 25, 2005; 280(8): 6610 - 6620.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Elbert, G. Rossi, and P. Brennwald
The Yeast Par-1 Homologs Kin1 and Kin2 Show Genetic and Physical Interactions with Components of the Exocytic Machinery
Mol. Biol. Cell, February 1, 2005; 16(2): 532 - 549.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. E. McRory, J. Hamid, C. J. Doering, E. Garcia, R. Parker, K. Hamming, L. Chen, M. Hildebrand, A. M. Beedle, L. Feldcamp, et al.
The CACNA1F Gene Encodes an L-Type Calcium Channel with Unique Biophysical Properties and Tissue Distribution
J. Neurosci., February 18, 2004; 24(7): 1707 - 1718.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. H. Widberg, N. J. Bryant, M. Girotti, S. Rea, and D. E. James
Tomosyn Interacts with the t-SNAREs Syntaxin4 and SNAP23 and Plays a Role in Insulin-stimulated GLUT4 Translocation
J. Biol. Chem., September 12, 2003; 278(37): 35093 - 35101.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
N. M. Alto, J. Soderling, and J. D. Scott
Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics
J. Cell Biol., August 19, 2002; 158(4): 659 - 668.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/46/42893    most recent
M103527200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pombo, I.
Right arrow Articles by Blank, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pombo, I.
Right arrow Articles by Blank, U.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement